Tom Marsilje, a relentless advocate for cancer patients, dies at 45

Tom Marsilje was eternally optimistic and willing to give of his time to help his fellow cancer patients find clinical trials and experimental therapies.

When Tom Marsilje launched a website in May to help people with late-stage colorectal cancer find possible treatments through clinical trials, he pointed out the irony: “The ultimate CRC clinical trial advocate is unlikely to ever do a clinical trial,” he said.

He was right.

Marsilje, a Novartis scientist who helped develop a cutting-edge lung cancer treatment — and who, after his own colon cancer diagnosis, became a fierce advocate for his fellow patients — died Tuesday afternoon at a hospital in San Diego. He was 45.

The cancer support community was reeling in the wake of the

You're reading a preview, sign up to read more.

More from STAT

STAT5 min readSociety
Opinion: Eliminating ‘Tensions’ In Health Care: A Litmus Test For Innovation
The challenge in applying the term innovation in health care is that the relationship between the "buyer" (patient) and the "seller" (provider) is convoluted by many other players.
STAT3 min readSociety
Opinion: Dreamers Like Me Fill Critical Gaps In Mental Health Care. The Dream And Promise Act Will Let Us Keep Doing That
Passing the American Dream and Promise Act to give Dreamers a pathway to citizenship would benefit not just the Dreamers but also the health care system and all of the…
STAT8 min read
Mental Health Apps Are Scooping Up Your Most Sensitive Data. Will You Benefit?
Mental health apps can put patients’ privacy at risk, and makers of some tools are using the data collected to create products that have nothing to do with health care.